Flare Therapeutics

Recent Finacing

Series B

Recent Raise

$123M

Flare Therapeutics operates a discovery platform of proprietary assays and an engine that identifies "switch sites" in transcriptional complexes to discover small-molecule precision medicines, initially advancing oncology programs.

Founded 2021

Massachusetts, United States

11-50

Private

flaretx.com

Highlights

Focus Areas

Biopharma

Biotechnology

Health Care

Life Science

Recent Investors

I

Financials

$205M

Total Raised

2

Funding rounds

14

Investors

Team

Upgrade to view the team

See the team members at Flare Therapeutics.